• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/10/24: Integrating AI Into Clinical Trials, GenAI Isn’t Ubiquitous in Business World...Yet & more

News
Article

The latest news for pharma industry insiders.

Integrating AI Into Clinical Trials

In part 2 of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes.

Digital Therapeutics Might Address Gaps in Care for Mental Health Patients

Pharmacists should be well educated on prescription digital therapeutics to better educate patients on software in comparison to traditional pharmacological products.

Generative AI Isn’t Ubiquitous in the Business World—at Least Not Yet

ChatGPT and other tools have racked up users, but some companies are proceeding with caution, or not at all

Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists

New Bayer innovation platform will help organizations build AI-powered apps that assist radiologists, reducing burnout and supporting more efficient diagnoses

David Manning on LinkedIn:
Redefining Trust in Pharma

Trust should be the cornerstone of an industry whose core mission is saving lives. Yet, pharma faces an uphill battle in public perception.

The article on Pharmaceutical Executive unpacks this paradox: https://hubs.li/Q02sf6Wh0

Despite groundbreaking contributions, particularly during the pandemic, pharma's trust metrics still lag behind, highlighting a complex relationship with public confidence. The piece introduces a compelling approach: a hierarchy of trust, advocating for a shift from compliance to profound commitments in benefits of medicines, integrity, and societal contributions.

This framework is a clarion call for the industry to reflect and innovate, making trust operational and tangible, beyond mere metrics.

As someone passionate about helping clients build better relationships with their customers, I find that the journey toward greater trust is pivotal. How pharma rises to this challenge will define its role and relevance in the years to come.

#Pharma #TrustInHealthcare #EthicalGovernance #Pharmaceuticals #PublicPerception

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs